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ABSTRACT
Objective: The aim of this study was to investigate the antibacterial activity of Genistein and Quercetin against pathogens of the urinary tract infection 
(UTI).
Methods: An in vitro study was carried out using the following bacterial strains involved in UTI diseases using well diffusion (WD) testing: Escherichia 
coli (ATCC 25922) and 10 strains were compiled from Aleppo Hospital. It was from women and men have UTI. The antibacterial activity of Genistein 
and Quercetin was determined in the form of inhibition zone using agar WD testing.
Results: In all experiments, results obtained indicated that Genistein and Quercetin had inhibitory effects on E. coli (ATCC 25922) and some 10 
strains. This study showed that Genistein and Quercetin were active against the tested bacterial strains.
Conclusion: The Genistein showed better antibacterial effect the tested bacterial strains. Therefore, the Genistein and Quercetin could be encouraged 
for further development in caries prevention and treatment.
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INTRODUCTION
A urinary tract infection (UTI) is an infection of the urethra, bladder, 
and/or kidneys, the major structures composing the urinary tract. 
Infections of the urethra (called urethritis) and of the bladder (called 
cystitis) are more common than infections of the kidney (called 
pyelonephritis). A bladder infection, if left untreated, may lead to a 
kidney infection due to bacteria ascending from the bladder, up the 
ureters, to the kidneys. Since kidneys are vital organs, essential to life, 
it is important that medical care is sought if any symptoms of a UTI 
are present. UTIs develop when bacteria get into the urinary system, 
a part of the body which normally has no bacteria [1]. About 85% of 
these infections are caused by a normal intestinal bacterium named 
Escherichia coli, commonly called E. coli. While infection with E. coli is 
most common, many bacteria including Staphylococcus, Streptococcus, 
Enterococcus, Proteus, and Klebsiella species may be responsible. E. coli 
is the most common bacterium isolated in urine UTIs. Figure 1 is shown 
the colony’s Escherichia coli in Eosin Methylene Blue Agar (EMB) agar.
E. coli is considered a normal component of gastrointestinal and distal 
urogenital flora but it can ascend the urethra and gain entrance to 
the urinary tract. Specific virulence factors found in E. coli allow it to 
adhere to and invade host cells, produce toxins, utilize host nutrients, 
and evade the host’s immune system.
Most UTIs are not serious, but some infections can lead to serious 
problems, such as kidney infections. Chronic kidney infections – 
infections that recur or last a long time – can cause permanent damage 
including kidney scars, poor kidney function, high blood pressure, and 
other problems. Some acute kidney infections – infections that develop 
suddenly – can be life threatening, especially if the bacteria enter the 
bloodstream, a condition called septicemia [2].
Most UTIs are caused by bacteria, which are treated with bacteria-
fighting medications called antibiotics or antimicrobials. The choice of 
medication and length of treatment depend on the patient’s history and 
the type of bacteria causing the infection. The synthetic drugs have been 
associated with severe side effects on human health. Due to these facts, 
it is urgent to explore an alternative antibacterial drug [3,4], which can 
affect the UTIs with less drug-resistance, for rebuilding/maintaining a 
“healthy” microbial community [5]. Recently, there has been a growing 
interest in the investigation and introduction of medicinal plants with 
various biological activities at the aspect of new drug development 
because of the advantages of ample materials source, ease of use, good 
efficacy, and small side effects [6].
Genistein and Quercetin are a natural extract of flavonoids Table1 is 
shown information on the Genistein and Quercetin, which widely exist 
in many parts of plants and attract much attention as natural molecules 
with a significant affinity toward targets of potential medicinal interest 
but also as a food supplement or prospective chemopreventive agent [7].
Many studies have demonstrated that Genistein and Quercetin have 
obvious pharmaceutical effects of anti-cancer [8,9], antioxidation [10,11], 
tyrosine kinase inhibiter [12], and anti-inflammatory [13,14]. Recently, 
Genistein showed significant antibacterial activity against Pseudomonas 
syringae (phytopathogenic bacteria) and Vibrio fluvialis (human 
pathogenic bacteria) [15], while the Quercetin have the ability to inhibit 
the acidogenicity of Streptococcus mutans [16].
In this study, we aimed to evaluate the antibacterial ability of Genistein 
and Quercetin on the UTI diseases-associated pathogen including E. coli.
METHODS
Strains and culture media
The Genistein and Quercetin were tested on the following strains: 
E. coli (ATCC 25922) was kindly donated by Aleppo University. It used 
as references for the antibacterial assay of Genistein and Quercetin. 
Addition the 10 strains were compiled from Aleppo Hospital. It was 
Research Article
from women and men have UTI. Table 2 is shown biochemical test 
results.
Preparation of Genistein and Quercetin solution
To examine the antibacterial activity of Genistein and Quercetin 
on E. coli, the Genistein and Quercetin purchased from Sigma were 
dissolved in dimethyl sulfoxide (DMSO, Sigma) to obtain concentrations 
of 400 μg/100 μL.
Antibacterial test using the agar diffusion method (well)
The well diffusion (WD) test was carried out with Muller-Hinton 
agar (MHA). The inoculum was prepared using 24-hr plate cultures 
of E. coli. The colonies were suspended in 0.85% saline, and the 
turbidity was compared with the 0.5 McFarland standard (equal to 
1.5×108 colony-forming units/ml). The suspension was loaded on 
a sterile cotton swab that was rotated several times and press firmly 
against the inside wall of the tube to remove excess inoculum from 
the swab. The dried surface of an MHA agar plate was inoculated by 
streaking the swab over the entire sterile agar surface. This procedure 
was repeated two more times, rotating the plate approximately 60° 
each time to ensure a uniform distribution of inoculum. Next, where 
7 mm wells were cut and filled with 100 μL of sample (400 μg/well). 
Ampicillin (AMP) (100 μL at a concentration of 1 mg/10 mL, equivalent 
to 10 μg/well) and ceftriaxone (CET) (100 μL at a concentration of 
3 mg/10 mL, equivalent to 30 μg/well) were used as positive control 
and DMSO as a negative control. The Petri dishes were pre-incubated 
for 3 hrs at room temperature, allowing the complete diffusion of the 
samples [17]. Then, the plates were incubated at 37°C±1°C for 24 hrs. 
The antibacterial activity was determined by measuring of inhibition 
zone diameters (mm) and was evaluated according the parameters 
suggested by [18]: Inhibition zones <9 mm, inactive; 9-12 mm, less 
active; 13-18 mm, active; >18 mm, very active [3]. All assays were 
performed in triplicate and repeated at least three times.
RESULTS FOR ANTIBACTERIAL ACTIVITY
In this study, we focused on some Flavonoid compounds action against 
bacteria involved in UTI. The antibacterial activity of Genistein and 
Quercetin against E. coli (ATCC 25922) and 10 strains were tested 
and compared to that of antibiotics AMP and CET (Tables 3 and 4). 
Among the 10 strains of E. coli tested, we observed the inhibitory 
effect on the growth of 10 bacterial strains. The Genistein and 
Quercetin, when used in combination with antibiotics, were found 
to increase each other activity against test bacteria. The relationship 
between the Genistein, Quercetin, and antibiotics in most of the cases 
was synergism.
DISCUSSION
Many natural plants and their extracts have been used for the medical 
purpose for centuries, and their biological and pharmacological effects 
have attracted more and more investigations in recent years [19,20]. 
Flavonoids (polyphenols) are bioactive molecules. These biological 
activities are related to the molecules structures; by their hydroxyl 
groups or by phenolic ring, phenolic compounds have capacity to link 
with proteins and bacterial membrane to form complexes [21]. Thus, 
several studies have reported the antimicrobial activities of plants 
extracts from various parts such as leaves, seeds, and flowers [22,23]. 
These results often pointed out that crud extract possessed low 
antibacterial activities against enteric bacteria. However, our results are 
similar to other studies carried out with pure molecules of flavonoids 
where the table 3 and table 4 presented that Genistein and Quercetin 
have an antibacterial activity. Moreover, the Genistein has a high 
antibacterial activity due to its bigger inhibition zone than Quercetin 
has [24].
These molecules showed antibacterial activities higher than crud 
extract. This difference may be explained by the presence of some 
residue in crud extract, which prevents direct contact between phenolic 
compounds and bacteria.
Fig. 1: Escherichia coli in eosin methylene blue agar
Table 1: : Structure of and information on the Genistein and Quercetin
Chemical name IUPAC name Information Compound structure










E. coli: Escherichia coli
Table 2: Biochemical identifications of the isolated E. coli





Positive Methyl red test
Negative Citrate
Negative Urease
Acid in slant and butt with gas production TSI
Positive Nitrate
E. coli: Escherichia coli
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In fact, Cowan [6] supposed that phenolic compounds without free 
hydroxyl groups have more antibacterial activity than those, which 
are provided. That increases their chemical affinity to microbial lipid 
membrane. There are less hydroxyl groups in Genistein molecular 
structure than Quercetin that might justify the difference of antibacterial 
activity between these two compounds in our study.
The results of this work are clear indication for the possible use of 
Genistein and Quercetin for control of some UTI.
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